Allogeneic versus autologous cell sources present trade-offs in availability, cost, immune risk

https://houstonregenerativemd.com/

Allogeneic versus autologous cell sources present trade-offs in availability, cost, immune risk, and standardization that shape clinical strategy and manufacturing.